43
Views
0
CrossRef citations to date
0
Altmetric
Original

CD34+-selected stem cell boost for delayed or insufficient engraftment after allogeneic stem cell transplantation

, , , , , , , , , , , & show all
Pages 375-380 | Published online: 07 Jul 2009

References

  • Appelbaum FR. Bone marrow and stem cell transplantation. Harrison's Principles of Internal Medicine CD-ROM15th edn, AS Fauci, DL Longo. McGraw-Hill Companies Inc., New York 2001
  • Brown RA, Herzig RH, Wolff SN, et al. High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancy. Blood 1990; 76: 473–9
  • Champlin RE, Passweg JR, Zhang MJ, et al. T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. Blood 2000; 95: 3996–4003
  • Lang P, Handgretinger R, Niethammer D, et al. Transplantation of highly purified CD34+ progenitor cells from unrelated donors in pediatric leukemia. Blood 2003; 101: 1630–6
  • Remberger M, Ringden O, Ljungman P, et al. Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation. Bone Marrow Transplant 1998; 22: 73–8
  • Lang P, Schumm M, Taylor G, et al. Clinical scale isolation of highly purified peripheral CD34+ progenitors for autologous and allogeneic transplantation in children. Bone Marrow Transplant 1999; 24: 583–9
  • Schumm M, Lang P, Taylor G, et al. Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device. J Hematother 1999; 8: 209–18
  • Mohty M, Faucher C, Chabannon C, et al. CD34(+) immunoselected cells for poor graft function following allogeneic BMT. Cytotherapy 2000; 2: 367–70
  • Arseniev L, Tischler HJ, Battmer K, et al. Treatment of poor marrow graft function with allogeneic CD34+ cells immunoselected from G-CSF-mobilized peripheral blood progenitor cells of the marrow donor. Bone Marrow Transplant 1994; 14: 791–7
  • Koehl U, Gunkel M, Gruettner HP, . Positive selection of hematopoietic progenitor cells for autologous and allogeneic transplantation in pediatric patients with solid tumors and leukemia. Transplant Hematol Onco, Th Büchner, et al. Springer-Verlag, Berlin 1999; 159–68
  • Koehl U, Zimmermann S, Esser R, et al. Autologous transplantation of CD133 selected haematopoietic progenitor cells in a paediatric patient with relapsed leukemia. Bone Marrow Transplant 2002; 29: 927–30
  • Sutherland DR, Anderson L, Keeney M, et al. The ISAGE guidelines for CD34+ cell determination by flow cytometry. J Hematother 1996; 5: 213–25
  • Reimann KA, O'German MR, Spritzler J, et al. Multisite comparison of CD4 and CD8 T-lymphocyte counting by single-versus multiple-platform methodologies: evaluation of Beckman Coulter flow-count fluorespheres and the tetraOne system. Clin Diagn Lab Immunol 2000; 7: 333–5
  • Lang P, Klingebiel T, Schumm M, et al. Correction of persistent thrombocytopenia by a boost of CD133+ selected stem cells in a patient transplanted for Wiskott-Aldrich syndrome 10 years ago. Bone Marrow Transplant 2004; 33: 879–80

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.